phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Dementia risk similar with SGLT2 inhibitors and dulaglutide

A nation-wide, population-based cohort study compared the effects of sodium-glucose cotransporter-2 (SGLT2) inhibitors versus dulaglutide on risk for dementia in older patients with type 2 diabetes (T2D).

August 26, 2024


December 17 2025

December 16 2025

December 15 2025

December 14 2025

December 13 2025

December 12 2025

December 11 2025

December 10 2025

December 9 2025

December 8 2025

December 7 2025

December 6 2025

December 5 2025

December 4 2025

Angell Street Psychiatry
Copyright 2025 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy